Editorial: Plant derived bioactive compounds in the management and treatment of metabolic syndrome

Kamran Ashraf, Abul Kalam Najmi, Nafees Ahemad

Research output: Contribution to journalEditorialOtherpeer-review

Abstract

Metabolic syndrome refers to a group of interrelated conditions that have been associated with the onset of cardiovascular diseases, type 2 diabetes, cognitive decline, and abnormal renal function. There is a substantial risk of cardiovascular disease and early mortality with these co-occurring diseases. The first line of treatment for metabolic syndrome is changing one’s lifestyle, which includes modifying food choices and increasing physical activity. Early treatment side effects associated with synthetic medication therapy for metabolic syndrome include altered renal enzyme functioning, gastrointestinal distress, flatulence, and hepatic abnormalities. A correct lifestyle and a balanced diet, not unbalanced towards an excess of simple sugars or saturated fats, can help prevent the dysmetabolisms underlying the metabolic syndrome. Likewise, a great contribution can come from appropriate and effective integration with bioactive substances present in certain foods or in food supplement formulations.
Original languageEnglish
Article number1423125
Number of pages2
JournalFrontiers in Pharmacology
Volume15
DOIs
Publication statusPublished - 18 Jun 2024

Keywords

  • bioactive compounds
  • cardiovascular disease
  • diabetes mallitus
  • metabolic syndrome
  • obesity

Cite this